Cargando…

Pediatric Cushing's disease: Management Issues

Cushing's disease (CD), caused by an ACTH-secreting pituitary corticotroph adenoma, is the commonest cause of Cushing syndrome in children over 5 years of age. It is rare in the pediatric age range and presents difficult diagnostic and therapeutic challenges. Key presenting features include wei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Savage, Martin O., Storr, Helen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Mini Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603019/ https://www.ncbi.nlm.nih.gov/pubmed/23565371 http://dx.doi.org/10.4103/2230-8210.104032

Ejemplares similares

Paediatric Cushing’s disease: Epidemiology, pathogenesis, clinical management and outcome
por: Ferrigno, Rosario, et al.
Publicado: (2021)

SUN-454 Rationale and Methods for a Phase II Trial Evaluating Osilodrostat in Pediatric Patients with Cushing's Disease
por: Savage, Martin, et al.
Publicado: (2019)

Molecular Basis of Primary Aldosteronism and Adrenal Cushing Syndrome
por: Vaduva, Patricia, et al.
Publicado: (2020)

Severe Cushing Syndrome Due to an ACTH-Producing Pheochromocytoma: A Case Presentation and Review of the Literature
por: Gabi, Jenan N, et al.
Publicado: (2018)

An Overview of the Heterogeneous Causes of Cushing Syndrome Resulting From Primary Macronodular Adrenal Hyperplasia (PMAH)
por: Charchar, Helaine Laiz Silva, et al.
Publicado: (2022)

Cushing disease in pediatrics: an update
por: Concepción-Zavaleta, Marcio José, et al.
Publicado: (2023)

The variability of responses to growth hormone therapy in children with short stature
por: Savage, Martin O., et al.
Publicado: (2012)

Microbial inoculation of seed for improved crop performance: issues and opportunities
por: O’Callaghan, Maureen
Publicado: (2016)

Thymoquinone: From Nigella sativa to a protective pharmacological compound in managing opioid dependence and amphetamine type stimulant issues
por: Mohd Adnan, Liyana Hazwani, et al.
Publicado: (2020)

Public Health issues in hospital management of Sarcopenic patients
por: Marinaki, Vassiliki, et al.
Publicado: (2017)

Coronavirus disease 2019 (COVID-19) and pediatric gastroenterology
por: Rohani, Pejman, et al.
Publicado: (2020)

Long-term outcomes of children treated for Cushing’s disease: a single center experience
por: Yordanova, Galina, et al.
Publicado: (2016)

Shedding light on pediatric diseases: multispectral optoacoustic tomography at the doorway to clinical applications
por: Regensburger, Adrian P., et al.
Publicado: (2020)

New options for the medical treatment of Cushing's syndrome
por: Trainer, Peter J.
Publicado: (2013)

Translational research approaches to study pediatric polycystic kidney disease
por: Liebau, Max Christoph, et al.
Publicado: (2021)

Continuous subcutaneous insulin infusion: practical issues
por: Saboo, Banshi D., et al.
Publicado: (2012)

Current Technologies and Related Issues for Mushroom Transformation
por: Kim, Sinil, et al.
Publicado: (2015)

Catecholamine-Secreting Tumors in Pediatric Patients With Cyanotic Congenital Heart Disease
por: Agarwal, Swashti, et al.
Publicado: (2019)

Recent advances and safety issues of transgenic plant-derived vaccines
por: Guan, Zheng-jun, et al.
Publicado: (2013)

Chemotherapy and the pediatric brain
por: Ikonomidou, Chrysanthy
Publicado: (2018)

Modified mRNA as a new therapeutic option for pediatric respiratory diseases and hemoglobinopathies
por: Antony, Justin S., et al.
Publicado: (2015)

Cushing’s syndrome: epidemiology and developments in disease management
por: Sharma, Susmeeta T, et al.
Publicado: (2015)

Cushing’s disease
por: Castinetti, Frederic, et al.
Publicado: (2012)

Cushing’s Disease
por: Nishioka, Hiroshi, et al.
Publicado: (2019)

Management of Graves Thyroidal and Extrathyroidal Disease: An Update
por: Kahaly, George J
Publicado: (2020)

Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care
por: Hartz, Jacob C, et al.
Publicado: (2018)

Clinical Utility of Anti-Mullerian Hormone in Pediatrics
por: Kanakatti Shankar, Roopa, et al.
Publicado: (2021)

An approach to the management of patients with residual Cushing’s disease
por: Blevins, Lewis S., et al.
Publicado: (2009)

Cushing’s Disease Management: Glimpse Into 2051
por: Dalan, Rinkoo, et al.
Publicado: (2022)

Pediatric Hypertrophic Cardiomyopathy: Exploring the Genotype‐Phenotype Association
por: Nguyen, Minh B., et al.
Publicado: (2022)

Pediatric herpes zoster ophthalmicus: a systematic review
por: Hakim, Farida E., et al.
Publicado: (2023)

Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management
por: Sarafoglou, Kyriakie, et al.
Publicado: (2023)

Congenital Micropenis: Etiology And Management
por: Stancampiano, Marianna Rita, et al.
Publicado: (2021)

Exploring the causes of mild COVID-19 involvement in pediatric patients
por: Naserghandi, A., et al.
Publicado: (2020)

Pediatric Parathyroid Carcinoma: A Case Report and Review of the Literature
por: Dutta, Aditya, et al.
Publicado: (2019)

Long noncoding RNAs as regulators of pediatric acute myeloid leukemia
por: Neyazi, Sina, et al.
Publicado: (2022)

Modeling pediatric medulloblastoma
por: Roussel, Martine F., et al.
Publicado: (2019)

Modern imaging in Cushing’s disease
por: Bashari, W. A., et al.
Publicado: (2022)

The impact of microbes in the orchestration of plants’ resistance to biotic stress: a disease management approach
por: Enebe, Matthew Chekwube, et al.
Publicado: (2018)

The Resilient Child: Sex-Steroid Hormones and COVID-19 Incidence in Pediatric Patients
por: Mihalopoulos, Meredith, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_370jgo31u286b2g1ualhlgquap